25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OXUR (Oxurion) Stock Analysis
Buy, Hold or Sell?

Let's analyze Oxurion together

I guess you are interested in Oxurion NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Oxurion’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Oxurion’s Price Targets

I'm going to help you getting a better view of Oxurion NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Oxurion NV

I send you an email if I find something interesting about Oxurion NV.

1. Quick Overview

1.1. Quick analysis of Oxurion (30 sec.)










1.2. What can you expect buying and holding a share of Oxurion? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-0.89
Expected worth in 1 year
€-0.20
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
€0.68
Return On Investment
2,536.7%

For what price can you sell your share?

Current Price per Share
€0.03
Expected price per share
€0.0001 - €0.057
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Oxurion (5 min.)




Live pricePrice per Share (EOD)
€0.03
Intrinsic Value Per Share
€3.18 - €22.91
Total Value Per Share
€2.30 - €22.02

2.2. Growth of Oxurion (5 min.)




Is Oxurion growing?

Current yearPrevious yearGrowGrow %
How rich?-$12.9m-$15.4m$2.4m19.2%

How much money is Oxurion making?

Current yearPrevious yearGrowGrow %
Making money$139.5k-$22.2m$22.3m16,040.3%
Net Profit Margin3,966.7%-7,212.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Oxurion (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#818 / 872

Most Revenue
#626 / 872

Most Profit
#163 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Oxurion?

Welcome investor! Oxurion's management wants to use your money to grow the business. In return you get a share of Oxurion.

First you should know what it really means to hold a share of Oxurion. And how you can make/lose money.

Speculation

The Price per Share of Oxurion is €0.027. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oxurion.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oxurion, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.89. Based on the TTM, the Book Value Change Per Share is €0.17 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.69 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oxurion.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps0.0141.6%0.0141.6%-1.79-6,628.7%-1.59-5,886.5%-2.03-7,527.5%-2.58-9,554.5%
Usd Book Value Change Per Share0.20743.6%0.20743.6%-0.81-3,006.3%-0.31-1,159.0%-1.21-4,498.4%-2.07-7,655.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.20743.6%0.20743.6%-0.81-3,006.3%-0.31-1,159.0%-1.21-4,498.4%-2.07-7,655.4%
Usd Price Per Share0.28-0.28-0.00-0.10-1.09-2.43-
Price to Earnings Ratio25.06-25.06-0.00-8.35-4.63-2.14-
Price-to-Total Gains Ratio1.40-1.40-0.00-0.44--0.13--0.29-
Price to Book Ratio-0.27--0.27-0.00--0.11--3.88--1.74-
Price-to-Total Gains Ratio1.40-1.40-0.00-0.44--0.13--0.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0316602
Number of shares31585
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.20-1.21
Usd Total Gains Per Share0.20-1.21
Gains per Quarter (31585 shares)6,341.63-38,362.12
Gains per Year (31585 shares)25,366.53-153,448.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1025367253570-153448-153458
2050733507240-306897-306906
3076100760910-460345-460354
401014661014580-613794-613802
501268331268250-767242-767250
601521991521920-920691-920698
701775661775590-1074139-1074146
802029322029260-1227588-1227594
902282992282930-1381036-1381042
1002536652536600-1534485-1534490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%5.014.00.026.3%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%9.010.00.047.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.019.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%9.010.00.047.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Oxurion NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1710.1710%-0.692+504%-0.267+256%-1.036+705%-1.763+1129%
Book Value Per Share---0.890-0.8900%-1.061+19%-0.773-13%-0.079-91%4.562-120%
Current Ratio--0.2160.2160%0.140+54%0.310-30%1.135-81%4.881-96%
Debt To Asset Ratio--2.9422.9420%3.013-2%2.446+20%1.733+70%0.919+220%
Debt To Equity Ratio----0%-0%-0%0.073-100%0.097-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---13315280.000-13315280.0000%-18050814.800+36%-14704987.600+10%3154765.040-522%58182092.120-123%
Eps--0.0100.0100%-1.526+16040%-1.355+14255%-1.733+18202%-2.200+23076%
Ev To Ebitda Ratio---47.897-47.8970%1.079-4539%-15.464-68%-9.713-80%-5.513-88%
Ev To Sales Ratio---4438.427-4438.4270%-68.634-98%-1509.496-66%-898.914-80%-440.339-90%
Free Cash Flow Per Share---0.166-0.1660%-0.786+372%-0.856+414%-1.389+735%-1.383+731%
Free Cash Flow To Equity Per Share---0.101-0.1010%-0.156+55%-0.258+156%-0.854+747%-1.041+933%
Gross Profit Margin--0.9160.9160%1.007-9%0.984-7%1.022-10%1.076-15%
Intrinsic Value_10Y_max--22.908----------
Intrinsic Value_10Y_min--3.185----------
Intrinsic Value_1Y_max---0.177----------
Intrinsic Value_1Y_min---0.968----------
Intrinsic Value_3Y_max--1.353----------
Intrinsic Value_3Y_min---1.811----------
Intrinsic Value_5Y_max--5.155----------
Intrinsic Value_5Y_min---1.445----------
Market Cap335556.000-789%2982720.0002982720.0000%11185.200+26567%1076679.067+177%11510565.040-74%25741992.120-88%
Net Profit Margin--39.66739.6670%-72.125+282%-28.570+172%-25.008+163%-15.336+139%
Operating Margin--45.33345.3330%-64.627+243%-23.415+152%-21.908+148%-13.798+130%
Operating Ratio---126.333-126.3330%47.046-369%-13.335-89%0.350-36236%3.839-3391%
Pb Ratio-0.030+89%-0.270-0.2700%-0.001-100%-0.107-60%-3.885+1340%-1.744+547%
Pe Ratio2.820-789%25.06525.0650%-0.001+100%8.352+200%4.630+441%2.142+1070%
Price Per Share0.027-789%0.2400.2400%0.001+26567%0.087+177%0.926-74%2.071-88%
Price To Free Cash Flow Ratio-0.162+89%-1.442-1.4420%-0.001-100%-0.485-66%-0.690-52%-0.754-48%
Price To Total Gains Ratio0.158-789%1.4021.4020%-0.001+100%0.444+216%-0.131+109%-0.287+121%
Quick Ratio--0.1690.1690%0.094+81%0.209-19%1.020-83%5.405-97%
Return On Assets--0.0210.0210%-2.896+13960%-1.839+8901%-1.576+7641%-0.957+4678%
Return On Equity----0%-0%-0%-0.2220%-0.3050%
Total Gains Per Share--0.1710.1710%-0.692+504%-0.267+256%-1.036+705%-1.763+1129%
Usd Book Value---12966610.800-12966610.8000%-15461903.600+19%-11267513.400-13%-1146099.240-91%66481729.600-120%
Usd Book Value Change Per Share--0.2010.2010%-0.812+504%-0.313+256%-1.215+705%-2.067+1129%
Usd Book Value Per Share---1.043-1.0430%-1.244+19%-0.907-13%-0.092-91%5.349-120%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---15613497.328-15613497.3280%-21166385.434+36%-17243068.460+10%3699277.486-522%68224321.220-123%
Usd Eps--0.0110.0110%-1.790+16040%-1.589+14255%-2.032+18202%-2.580+23076%
Usd Free Cash Flow---2424936.800-2424936.8000%-11451611.600+372%-12472164.467+414%-20241890.240+735%-20149372.100+731%
Usd Free Cash Flow Per Share---0.195-0.1950%-0.921+372%-1.004+414%-1.629+735%-1.621+731%
Usd Free Cash Flow To Equity Per Share---0.118-0.1180%-0.183+55%-0.303+156%-1.002+747%-1.221+933%
Usd Market Cap393472.966-789%3497537.4723497537.4720%13115.766+26567%1262513.874+177%13497288.566-74%30185059.960-88%
Usd Price Per Share0.032-789%0.2810.2810%0.001+26567%0.102+177%1.086-74%2.429-88%
Usd Profit--139539.400139539.4000%-22243049.400+16040%-19752447.000+14255%-25258976.600+18202%-32060760.160+23076%
Usd Revenue--3517.8003517.8000%308393.800-99%336536.200-99%953792.840-100%4390800.700-100%
Usd Total Gains Per Share--0.2010.2010%-0.812+504%-0.313+256%-1.215+705%-2.067+1129%
 EOD+2 -6MRQTTM+0 -0YOY+30 -63Y+24 -125Y+20 -1710Y+20 -17

3.3 Fundamental Score

Let's check the fundamental score of Oxurion NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-152.820
Price to Book Ratio (EOD)Between0-1-0.030
Net Profit Margin (MRQ)Greater than039.667
Operating Margin (MRQ)Greater than045.333
Quick Ratio (MRQ)Greater than10.169
Current Ratio (MRQ)Greater than10.216
Debt to Asset Ratio (MRQ)Less than12.942
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.021
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Oxurion NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.846
Ma 20Greater thanMa 500.033
Ma 50Greater thanMa 1000.048
Ma 100Greater thanMa 2000.098
OpenGreater thanClose0.029
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Fundamental data was last updated by Penke on 2025-07-09 16:17:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Oxurion earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Oxurion to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 3,966.7%Β means thatΒ €39.67 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oxurion NV:

  • The MRQ is 3,966.7%. The company is making a huge profit. +2
  • The TTM is 3,966.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ3,966.7%TTM3,966.7%0.0%
TTM3,966.7%YOY-7,212.5%+11,179.2%
TTM3,966.7%5Y-2,500.8%+6,467.5%
5Y-2,500.8%10Y-1,533.6%-967.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3,966.7%-93.6%+4,060.3%
TTM3,966.7%-140.9%+4,107.6%
YOY-7,212.5%-197.6%-7,014.9%
3Y-2,857.0%-248.5%-2,608.5%
5Y-2,500.8%-343.4%-2,157.4%
10Y-1,533.6%-496.2%-1,037.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Oxurion is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Oxurion to theΒ Biotechnology industry mean.
  • 2.1% Return on Assets means thatΒ Oxurion generatedΒ €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oxurion NV:

  • The MRQ is 2.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.1%0.0%
TTM2.1%YOY-289.6%+291.7%
TTM2.1%5Y-157.6%+159.7%
5Y-157.6%10Y-95.7%-61.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%-11.6%+13.7%
TTM2.1%-11.6%+13.7%
YOY-289.6%-11.4%-278.2%
3Y-183.9%-11.8%-172.1%
5Y-157.6%-12.0%-145.6%
10Y-95.7%-13.7%-82.0%
4.3.1.3. Return on Equity

Shows how efficient Oxurion is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Oxurion to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Oxurion generated €0.00Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oxurion NV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-22.2%+22.2%
5Y-22.2%10Y-30.5%+8.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--14.9%+14.9%
YOY--14.6%+14.6%
3Y--16.8%+16.8%
5Y-22.2%-17.5%-4.7%
10Y-30.5%-19.9%-10.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Oxurion NV.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Oxurion is operatingΒ .

  • Measures how much profit Oxurion makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Oxurion to theΒ Biotechnology industry mean.
  • An Operating Margin of 4,533.3%Β means the company generated €45.33 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oxurion NV:

  • The MRQ is 4,533.3%. The company is operating very efficient. +2
  • The TTM is 4,533.3%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ4,533.3%TTM4,533.3%0.0%
TTM4,533.3%YOY-6,462.7%+10,996.1%
TTM4,533.3%5Y-2,190.8%+6,724.2%
5Y-2,190.8%10Y-1,379.8%-811.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4,533.3%-232.5%+4,765.8%
TTM4,533.3%-250.5%+4,783.8%
YOY-6,462.7%-209.2%-6,253.5%
3Y-2,341.5%-234.1%-2,107.4%
5Y-2,190.8%-346.1%-1,844.7%
10Y-1,379.8%-477.5%-902.3%
4.3.2.2. Operating Ratio

Measures how efficient Oxurion is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of -126.33 means that the operating costs are €-126.33 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Oxurion NV:

  • The MRQ is -126.333.
  • The TTM is -126.333.
Trends
Current periodCompared to+/- 
MRQ-126.333TTM-126.3330.000
TTM-126.333YOY47.046-173.379
TTM-126.3335Y0.350-126.683
5Y0.35010Y3.839-3.489
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-126.3332.111-128.444
TTM-126.3332.694-129.027
YOY47.0463.096+43.950
3Y-13.3353.652-16.987
5Y0.3504.745-4.395
10Y3.8396.614-2.775
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Oxurion NV.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Oxurion is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.22Β means the company has €0.22 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Oxurion NV:

  • The MRQ is 0.216. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.216. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.216TTM0.2160.000
TTM0.216YOY0.140+0.076
TTM0.2165Y1.135-0.920
5Y1.13510Y4.881-3.745
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2163.661-3.445
TTM0.2163.846-3.630
YOY0.1404.140-4.000
3Y0.3104.688-4.378
5Y1.1355.746-4.611
10Y4.8816.147-1.266
4.4.3.2. Quick Ratio

Measures if Oxurion is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Oxurion to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.17Β means the company can pay off €0.17 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oxurion NV:

  • The MRQ is 0.169. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.169. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.169TTM0.1690.000
TTM0.169YOY0.094+0.076
TTM0.1695Y1.020-0.851
5Y1.02010Y5.405-4.385
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1692.848-2.679
TTM0.1693.169-3.000
YOY0.0943.786-3.692
3Y0.2094.311-4.102
5Y1.0205.703-4.683
10Y5.4056.368-0.963
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Oxurion NV.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of OxurionΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Oxurion to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.94Β means that Oxurion assets areΒ financed with 294.2% credit (debt) and the remaining percentage (100% - 294.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Oxurion NV:

  • The MRQ is 2.942. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.942. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.942TTM2.9420.000
TTM2.942YOY3.013-0.071
TTM2.9425Y1.733+1.209
5Y1.73310Y0.919+0.814
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9420.329+2.613
TTM2.9420.349+2.593
YOY3.0130.331+2.682
3Y2.4460.340+2.106
5Y1.7330.349+1.384
10Y0.9190.379+0.540
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Oxurion is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Oxurion to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oxurion NV:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.073-0.073
5Y0.07310Y0.097-0.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM-0.437-0.437
YOY-0.414-0.414
3Y-0.450-0.450
5Y0.0730.464-0.391
10Y0.0970.515-0.418
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Oxurion generates.

  • Above 15 is considered overpriced butΒ always compareΒ Oxurion to theΒ Biotechnology industry mean.
  • A PE ratio of 25.06 means the investor is paying €25.06Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oxurion NV:

  • The EOD is 2.820. Based on the earnings, the company is cheap. +2
  • The MRQ is 25.065. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.065. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD2.820MRQ25.065-22.245
MRQ25.065TTM25.0650.000
TTM25.065YOY-0.001+25.065
TTM25.0655Y4.630+20.435
5Y4.63010Y2.142+2.488
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.820-2.356+5.176
MRQ25.065-2.077+27.142
TTM25.065-2.574+27.639
YOY-0.001-3.760+3.759
3Y8.352-3.773+12.125
5Y4.630-6.193+10.823
10Y2.142-6.876+9.018
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oxurion NV:

  • The EOD is -0.162. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.442. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.442. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.162MRQ-1.442+1.280
MRQ-1.442TTM-1.4420.000
TTM-1.442YOY-0.001-1.441
TTM-1.4425Y-0.690-0.752
5Y-0.69010Y-0.754+0.064
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.162-3.246+3.084
MRQ-1.442-2.705+1.263
TTM-1.442-3.704+2.262
YOY-0.001-4.402+4.401
3Y-0.485-5.070+4.585
5Y-0.690-8.477+7.787
10Y-0.754-9.305+8.551
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Oxurion is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -0.27 means the investor is paying €-0.27Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Oxurion NV:

  • The EOD is -0.030. Based on the equity, the company is expensive. -2
  • The MRQ is -0.270. Based on the equity, the company is expensive. -2
  • The TTM is -0.270. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.030MRQ-0.270+0.239
MRQ-0.270TTM-0.2700.000
TTM-0.270YOY-0.001-0.269
TTM-0.2705Y-3.885+3.615
5Y-3.88510Y-1.744-2.140
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0302.038-2.068
MRQ-0.2701.843-2.113
TTM-0.2702.125-2.395
YOY-0.0012.442-2.443
3Y-0.1072.492-2.599
5Y-3.8853.652-7.537
10Y-1.7444.311-6.055
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Income before Tax  -28,560-1,032-29,592-2,094-31,68612,720-18,96619,088122
Net Income  -28,012-1,146-29,158-2,527-31,68512,716-18,96919,088119
EBIT  -28,506-347-28,853-1,463-30,31613,319-16,99717,133136
EBITDA  -27,396-780-28,176-1,787-29,96313,234-16,72917,007278
Operating Income  -29,7551,067-28,6885,909-22,77910,669-12,11012,492382
Total Operating Expenses  30,174-1,64728,527-6,01922,508-10,29412,214-12,636-422
Net Income from Continuing Operations  -28,560-1,035-29,595-2,098-31,69312,724-18,96919,088119



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets5,695
Total Liabilities16,753
Total Stockholder Equity-11,058
 As reported
Total Liabilities 16,753
Total Stockholder Equity+ -11,058
Total Assets = 5,695

Assets

Total Assets5,695
Total Current Assets3,585
Long-term Assets2,110
Total Current Assets
Cash And Cash Equivalents 455
Net Receivables 2,361
Other Current Assets 769
Total Current Assets  (as reported)3,585
Total Current Assets  (calculated)3,585
+/-0
Long-term Assets
Property Plant Equipment 40
Long-term Assets Other 2,070
Long-term Assets  (as reported)2,110
Long-term Assets  (calculated)2,110
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities16,623
Long-term Liabilities130
Total Stockholder Equity-11,058
Total Current Liabilities
Short-term Debt 11,319
Short Long Term Debt 11,195
Accounts payable 4,521
Other Current Liabilities 783
Total Current Liabilities  (as reported)16,623
Total Current Liabilities  (calculated)27,818
+/- 11,195
Long-term Liabilities
Capital Lease Obligations 132
Long-term Liabilities  (as reported)130
Long-term Liabilities  (calculated)132
+/- 2
Total Stockholder Equity
Common Stock74,893
Retained Earnings -111,451
Other Stockholders Equity 25,500
Total Stockholder Equity (as reported)-11,058
Total Stockholder Equity (calculated)-11,058
+/-0
Other
Capital Stock74,893
Cash and Short Term Investments 455
Common Stock Shares Outstanding 1,269
Liabilities and Stockholders Equity 5,695
Net Debt 10,872
Net Invested Capital 137
Net Working Capital -13,038
Property Plant and Equipment Gross 11,092
Short Long Term Debt Total 11,327



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
37,334
51,997
67,203
101,219
142,937
129,089
239,171
271,154
220,714
178,946
121,636
150,437
114,864
65,030
34,284
18,876
11,993
6,550
5,695
5,6956,55011,99318,87634,28465,030114,864150,437121,636178,946220,714271,154239,171129,089142,937101,21967,20351,99737,334
   > Total Current Assets 
34,218
48,354
61,448
80,108
113,477
87,784
159,751
191,634
149,168
116,693
91,439
124,283
91,089
57,015
27,054
13,409
7,106
2,740
3,585
3,5852,7407,10613,40927,05457,01591,089124,28391,439116,693149,168191,634159,75187,784113,47780,10861,44848,35434,218
       Cash And Cash Equivalents 
32,043
40,111
30,356
75,929
85,866
57,548
139,398
164,570
123,223
93,341
58,251
56,175
64,652
42,492
24,511
9,740
3,496
1,624
455
4551,6243,4969,74024,51142,49264,65256,17558,25193,341123,223164,570139,39857,54885,86675,92930,35640,11132,043
       Short-term Investments 
718
6,710
28,565
742
23,289
22,831
8,833
7,791
3,853
8,044
21,817
49,555
20,475
10,444
288
247
95
50
0
0509524728810,44420,47549,55521,8178,0443,8537,7918,83322,83123,28974228,5656,710718
       Net Receivables 
0
1,095
1,714
3,119
3,431
0
0
9,874
11,506
6,274
5,181
2,626
2,739
2,293
1,410
974
825
115
2,361
2,3611158259741,4102,2932,7392,6265,1816,27411,5069,874003,4313,1191,7141,0950
       Other Current Assets 
1,457
438
813
318
891
7,405
4,720
3,288
3,362
2,536
2,593
13,723
3,369
2,920
1,765
3,281
3,194
518
769
7695183,1943,2811,7652,9203,36913,7232,5932,5363,3623,2884,7207,4058913188134381,457
   > Long-term Assets 
3,116
3,643
5,755
21,111
29,460
41,305
79,420
79,520
67,885
60,373
27,645
24,594
21,064
8,015
7,230
5,467
4,887
3,810
2,110
2,1103,8104,8875,4677,2308,01521,06424,59427,64560,37367,88579,52079,42041,30529,46021,1115,7553,6433,116
       Property Plant Equipment 
530
1,057
1,004
1,042
894
1,492
2,699
3,634
2,911
2,088
1,743
991
614
2,552
1,299
372
1,062
245
40
402451,0623721,2992,5526149911,7432,0882,9113,6342,6991,4928941,0421,0041,057530
       Goodwill 
2,586
2,586
2,586
2,586
2,586
0
2,586
2,586
2,586
2,586
0
0
0
0
0
0
0
0
0
0000000002,5862,5862,5862,58602,5862,5862,5862,5862,586
       Intangible Assets 
0
0
2,092
17,357
25,832
0
72,338
69,209
62,388
55,699
25,902
23,603
20,450
1,982
2,127
1,000
0
0
0
0001,0002,1271,98220,45023,60325,90255,69962,38869,20972,338025,83217,3572,09200
       Other Assets 
0
0
0
0
0
0
0
0
3,661
1,880
2,552
1,560
2,711
3,481
3,804
4,095
0
0
0
0004,0953,8043,4812,7111,5602,5521,8803,66100000000
> Total Liabilities 
2,056
3,562
4,810
7,501
4,747
11,060
11,205
12,382
12,702
8,931
11,777
17,080
9,554
11,724
9,236
19,984
16,576
19,736
16,753
16,75319,73616,57619,9849,23611,7249,55417,08011,7778,93112,70212,38211,20511,0604,7477,5014,8103,5622,056
   > Total Current Liabilities 
2,027
3,601
4,810
7,501
4,747
11,060
11,205
12,382
12,702
8,931
11,777
17,080
9,554
10,389
7,693
10,913
12,349
19,607
16,623
16,62319,60712,34910,9137,69310,3899,55417,08011,7778,93112,70212,38211,20511,0604,7477,5014,8103,6012,027
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
898
649
3,622
3,948
12,217
11,319
11,31912,2173,9483,6226498980000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,401
3,809
12,006
11,195
11,19512,0063,8093,401000000000000000
       Accounts payable 
1,785
0
3,865
6,688
4,034
9,336
9,303
10,352
7,369
4,128
5,941
3,298
5,054
4,725
4,377
4,979
5,040
4,940
4,521
4,5214,9405,0404,9794,3774,7255,0543,2985,9414,1287,36910,3529,3039,3364,0346,6883,86501,785
       Other Current Liabilities 
242
3,601
945
813
713
1,724
1,902
2,030
5,333
4,803
5,836
13,782
4,500
4,766
2,667
2,312
3,361
2,450
783
7832,4503,3612,3122,6674,7664,50013,7825,8364,8035,3332,0301,9021,7247138139453,601242
   > Long-term Liabilities 
29
-39
0
6,688
4,034
9,336
9,303
0
0
0
0
0
5,054
1,335
1,543
9,071
4,227
129
130
1301294,2279,0711,5431,3355,054000009,3039,3364,0346,6880-3929
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,335
0
0
0
0
0
000001,3350000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
801
1,096
594
0
0
0
0005941,0968010000000000000
> Total Stockholder Equity
35,278
48,435
62,393
93,718
138,190
118,029
227,966
258,772
208,012
169,938
109,816
132,630
104,888
53,160
25,180
-1,078
-4,583
-13,186
-11,058
-11,058-13,186-4,583-1,07825,18053,160104,888132,630109,816169,938208,012258,772227,966118,029138,19093,71862,39348,43535,278
   Common Stock
95,974
110,309
111,338
125,122
138,095
138,351
150,938
151,991
151,991
151,991
151,991
151,991
137,564
100,644
44,913
46,029
65,443
72,993
74,893
74,89372,99365,44346,02944,913100,644137,564151,991151,991151,991151,991151,991150,938138,351138,095125,122111,338110,30995,974
   Retained Earnings -111,451-92,373-73,404-41,719-12,561-34,747-19,853-163,546-186,334-126,020-88,136-36,792-63,193-93,608-71,971-58,029-43,959-56,054-40,087
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
-20,609
-5,820
-4,986
46,520
90,902
73,286
155,754
157,661
157,661
157,661
157,661
157,661
-25,659
-12,737
-7,172
234
250
250
25,500
25,500250250234-7,172-12,737-25,659157,661157,661157,661157,661157,661155,75473,28690,90246,520-4,986-5,820-20,609



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue3
Cost of Revenue-43
Gross Profit-40-40
 
Operating Income (+$)
Gross Profit-40
Operating Expense--422
Operating Income382382
 
Operating Expense (+$)
Research Development1,235
Selling General Administrative2,013
Selling And Marketing Expenses10
Operating Expense-4223,258
 
Net Interest Income (+$)
Interest Income1
Interest Expense-218
Other Finance Cost-0
Net Interest Income-217
 
Pretax Income (+$)
Operating Income382
Net Interest Income-217
Other Non-Operating Income Expenses0
Income Before Tax (EBT)122642
EBIT - interestExpense = -82
122
337
Interest Expense218
Earnings Before Interest and Taxes (EBIT)136340
Earnings Before Interest and Taxes (EBITDA)278
 
After tax Income (+$)
Income Before Tax122
Tax Provision-3
Net Income From Continuing Ops119119
Net Income119
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses379
Total Other Income/Expenses Net-260217
 

Technical Analysis of Oxurion
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oxurion. The general trend of Oxurion is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oxurion's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Oxurion Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oxurion NV.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.035 < 0.0526 < 0.057.

The bearish price targets are: 0.025 > 0.0001.

Know someone who trades $OXUR? Share this with them.πŸ‘‡

Oxurion NV Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oxurion NV. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oxurion NV Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oxurion NV. The current macd is -0.00655978.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Oxurion price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Oxurion. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Oxurion price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Oxurion NV Daily Moving Average Convergence/Divergence (MACD) ChartOxurion NV Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oxurion NV. The current adx is 84.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Oxurion shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Oxurion NV Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oxurion NV. The current sar is 0.02600459.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Oxurion NV Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oxurion NV. The current rsi is 22.85. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Oxurion NV Daily Relative Strength Index (RSI) ChartOxurion NV Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oxurion NV. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oxurion price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Oxurion NV Daily Stochastic Oscillator ChartOxurion NV Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oxurion NV. The current cci is -104.74057484.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Oxurion NV Daily Commodity Channel Index (CCI) ChartOxurion NV Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oxurion NV. The current cmo is -54.53343692.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Oxurion NV Daily Chande Momentum Oscillator (CMO) ChartOxurion NV Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oxurion NV. The current willr is -81.81818182.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Oxurion NV Daily Williams %R ChartOxurion NV Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Oxurion NV.

Oxurion NV Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oxurion NV. The current atr is 0.00421155.

Oxurion NV Daily Average True Range (ATR) ChartOxurion NV Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oxurion NV. The current obv is -127,294,753.

Oxurion NV Daily On-Balance Volume (OBV) ChartOxurion NV Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oxurion NV. The current mfi is 13.05.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Oxurion NV Daily Money Flow Index (MFI) ChartOxurion NV Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oxurion NV.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Oxurion NV Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oxurion NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.846
Ma 20Greater thanMa 500.033
Ma 50Greater thanMa 1000.048
Ma 100Greater thanMa 2000.098
OpenGreater thanClose0.029
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Oxurion with someone you think should read this too:
  • Are you bullish or bearish on Oxurion? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oxurion? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oxurion NV

I send you an email if I find something interesting about Oxurion NV.


Comments

How you think about this?

Leave a comment

Stay informed about Oxurion NV.

Receive notifications about Oxurion NV in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.